Topical nasal steroids Topical nasal steroids are anti-inflammatory drugs that stop the allergic reaction. In addition to other beneficial actions, they reduce the number of mast cells in the nose and reduce mucus secretion and nasal swelling. The combination of antihistamines and nasal steroids is a very effective way to treat allergic rhinitis. This medication should not be confused with anabolic steroids that have serious side effects. Cromolyn sodium Cromolyn sodium stops allergic reactions from starting. It is administered as a nasal spray, and it can prevent the release of chemicals like histamine from the mast cell. Click here for allergy medication online.

In January 1997, 62 subjects who had been the placebos in the 1995 study were invited to receive the vitamin B12. In June 1997, the 62 placebo subjects were sent a questionnaire kingsize bed asking: how would you compare your overall allergy (hay fever) symptoms this spring to the last two springs? 20 people responded, with 15 reporting having had the b12 treatment, bed and 5 not. 12 of the 15 reported at least a slight improvement in overall allergy symptoms, and 1 of the 5. improvement ratios - 12:3 having received treatment, 1:4 not having received treatment.8 a bioequivalence study showed that a 3000 mcg lozenge delivered an equivalent amount of cyanocobalamin to the blood as a 15 mcg injection.9 from the spring to the summer patients with demonstrated allergic rhinitis received with the cyanocobalamin (or placebo) kingsize containing lozenge twice daily for 21 consecutive days. all subjects bed also received c and b oral multivitamins kingsize for 21 days. twice daily subjects maintained a nine-week diary on sneezing, runny nose, nasal congestion, itchy eyes, itchy nose and antihistamine (chlorpheniramine) use. in the post-treatment period, the active group (n=15) recorded on average a greater reduction in symptoms and in antihistamine bed use than the placebo group (n=9). the results yielded reductions (0.1>p>0.01) in total weekly symptom/rescue medication for the active group compared to the placebo for weeks 2, 6, 8 and 9. the results tend to replicate those of the studies on injectable cyanocobalamin.10

in 1992 in el paso, tx a randomized, double-blind, placebo controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. the average ige level of the placebo treated subjects remained essentially flat, while the average ige level for active treated subjects was reduced significantly kingsize from baseline to day 30.7 in 1993 in el paso, tx, valid subjects (n=66) returned a second set of bed symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set kingsize of symptom diaries). the active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. the placebo group had increased symptoms bed in 1993. (the relevant pollen counts at the study site in 1993 were much higher than in 1992, leading to expectation of higher symptoms.)7

©2003 www.mattress-air-beds.com All rights reserved.